Solid Biosciences Inc (NAS:SLDB)
$ 8.49 -0.63 (-6.91%) Market Cap: 327.38 Mil Enterprise Value: 169.77 Mil PE Ratio: 0 PB Ratio: 1.53 GF Score: 40/100

Solid Biosciences Inc at Chardan Genetic Medicines Conference (Virtual) Transcript

Oct 05, 2021 / 06:30PM GMT
Release Date Price: $35.25 (-1.26%)
Geulah Livshits
Chardan Capital Markets LLC - Analyst

Good afternoon. It's now my pleasure to introduce our next fireside chat guest. From Solid Biosciences, we have Dr. Carl Morris, Chief Scientific Officer; and Dr. Joel Schneider, Chief Operating Officer. (Operator Instructions). Thank you both for joining us today. Please go ahead with your overview and then we will dive into the Q&A.

Joel Schneider
Solid Biosciences Inc. - COO

Thank you, Geulah. And thank you to the Chardan Conference for hosting us and giving us this opportunity to talk about all the current ongoings at Solid, and to provide a bit of a corporate recap of where we are in the development of our promising programs for Duchenne muscular dystrophy. I will just provide a quick overview over a few slides of the work that we're currently going through, and then would love to dive into the Q&A with you, Geulah. I will skip over the forward-looking statements.

As a quick introduction for those of you that are not familiar with Solid, we consider ourselves innovators in gene

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot